Luminex Corp. (NASDAQ:LMNX) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research note issued to investors on Monday. According to Zacks, “We believe that Luminex's Assay business will be its key growth driver over the long term. We are also optimistic with regard to the company’s products […]